1. Evaluation of pharmacy-based HIV testing in a high-risk New York City community
- Author
-
Alexis V. Rivera, Natalie D. Crawford, Vijay Nandi, Silvia Amesty, and Crystal M. Fuller
- Subjects
medicine.medical_specialty ,Epidemiology ,HIV infections--Diagnosis ,Pharmacy ,Hiv testing ,Pharmacology ,Drug abuse ,Limited access ,AIDS (Disease)--Patients--Drug use ,Medicine ,HIV infections--Risk factors ,Medical prescription ,Syringe ,Intravenous drug abusers ,Public health ,business.industry ,virus diseases ,medicine.disease ,Substance abuse ,Infectious Diseases ,Family medicine ,HIV infections—Prevention ,Poster Presentation ,business - Abstract
Injection drug users (IDUs) face limited access to HIV testing and experience delayed HIV diagnoses. New York City (NYC) pharmacies play an important role in HIV prevention among IDUs through the Expanded Syringe Access Program (ESAP), which provides access to sterile syringes without a prescription. We examined in-pharmacy HIV testing among syringe/non-syringe customers in ESAP pharmacies in NYC.
- Published
- 2014
- Full Text
- View/download PDF